A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group.
Audrey E. Evans(Children's Hospital of Philadelphia), G. Denman Hammond, Jerry Z. Finklestein, A. Condon Dalton, H N Sather, Richard S. Ungerleider(Theradex Oncology (United States)), Giulio J. D’Angio(University of Pennsylvania), Alfred A. de Lorimier
Cited by 55
Related Papers
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914
How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment Trials
|Journal of Clinical Oncology|2002|531
Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfon-m-anisidide and adriamycin
|Biochemistry|1981|375
Representation of older patients in cancer treatment trials
|Cancer|1994|349
Representation of African-Americans, Hispanics, and Whites in National Cancer Institute Cancer Treatment Trials
|JNCI Journal of the National Cancer Institute|1996|275